Loading...
XNAS
OSRH
Market cap763kUSD
Jul 09, Last price  
0.33USD
1D
6.92%
1Q
-38.50%
IPO
-89.42%
Name

Bellevue Life Sciences Acquisition Corp

Chart & Performance

D1W1MN
XNAS:OSRH chart
P/E
P/S
0.26
EPS
Div Yield, %
Shrs. gr., 5y
-10.69%
Rev. gr., 5y
%
Revenues
3m
-17.69%
00003,530,3032,905,805
Net income
-18m
L+74.37%
-23,812-3,308-35,388403,780-10,328,910-18,010,899
CFO
-4m
L+97.81%
-23,812-461-410-818,766-2,187,946-4,328,034

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Bellevue Life Sciences Acquisition Corp. currently does not engage in substantial operational activities. Its core mission is to orchestrate a business combination, which could manifest as a merger, share exchange, asset acquisition, stock purchase, recapitalization, or reorganization, with one or more enterprises or organizations within the healthcare domain. This firm, established in 2020, maintains its principal office in Bellevue, Washington, and operates as a subordinate entity of Bellevue Global Life Sciences Investors LLC.
URL
IPO date
Feb 10, 2023
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT